Location History:
- Favaro Veneto, IT (2005)
- Montecchio Maggiore, IT (2009 - 2014)
Company Filing History:
2 out of 506 
1 out of 107 
1 out of 39 Years Active: 2005-2014
Title: Federico Sbrogiò: Innovator in Pharmaceutical Chemistry
Introduction
Federico Sbrogiò is a notable inventor based in Montecchio Maggiore, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of antidepressants. With a total of 4 patents, Sbrogiò's work has had a meaningful impact on the development of important medications.
Latest Patents
Sbrogiò's latest patents include innovative methods for the preparation of citalopram and escitalopram. One patent discloses intermediates for the manufacture of 5-alkoxycarbonylphthtalides, which are useful in the synthesis of these well-known antidepressants. Another patent outlines a process for the preparation of pure citalopram, detailing a cyanide exchange reaction that enhances the efficiency of the synthesis. This process involves the initial purification of the crude citalopram product, followed by a film distillation process to yield a high-quality final product.
Career Highlights
Throughout his career, Sbrogiò has worked with prominent companies in the pharmaceutical industry, including H. Lundbeck A/S and Merz Pharma GmbH & Co. KGaA. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical innovations.
Collaborations
Sbrogiò has collaborated with esteemed colleagues such as Andrea Castellin and Thomas Pittelkow. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.
Conclusion
Federico Sbrogiò's contributions to pharmaceutical chemistry, particularly in the synthesis of antidepressants, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.